Children and young people’s gender services
The interim service specification for specialist gender incongruence services for children and young people supporting Phase 1 providers in developing their new services has now been published following public consultation. Following advice from the Cass Review highlighting the uncertainties surrounding the use of hormone treatments, NHS England will in future only commission puberty suppressing hormones in the context of a formal research protocol. NHS England are now engaging with stakeholders to test an interim clinical commissioning policy proposing that, outside of a research setting, puberty suppressing hormones should not be routinely commissioned for children and adolescents who have gender incongruence / dysphoria.